Shares of Avon soared in early trading today as traders and investors alike saw the refusal of a buyout offered by Coty for $10 billion. This occurrence has been viewed as a display of strength for the beauty care company. Signs that Avon has been struggling financially have momentarily been disregarded by traders. This refusal was shown as a display of previously unknown strength by the cosmetic company and has played a huge role in reassuring investors and traders that this company is not going anywhere soon.
The stock roared up by over 16 percent early on Monday morning. Its current price is up to well over $22 per share, offering traders an increase of over $3 per share. For day traders using Trade Vantage, this is a dream come true. The profits came suddenly; the opening bell saw the majority of the profit plus a little jump in the first few minutes of trading. But huge gains like this rarely last long, and Avon is no exception. Traders who had held the stock overnight quickly saw a sell off as the price dropped from over $23 down to under $22. The stock has since gained back a little of this loss, but this should emerge as a sign that Avon isn’t necessarily going to hold onto their 16 plus percent gains.
The company had problems before they refused the Coty buyout, and those problems haven’t gone away just because of this display. But this might be an indication that the company is still doing better than most experts originally thought.
Coty has also recently been growing. They recently bought out other beauty product companies such as OPI and Philosophy, Inc. The Coty executives viewed Avon as another major feather in their cap, but Avon wanted nothing to do with this. Instead, there is hope that they can continue to rebuild their company and their image. Monday’s action is an indicator that growth is possible, but don’t expect these immediate gains to last. It’s very likely that Avon stock will fall back to a normal price before it starts growing again. Short term gains are great, but they severely overestimate the company’s current financial health.
